Valid Insight
Consultancy specialising in market access for pharmaceuticals, MedTech/diagnostics and medical nutrition. Services span early development through post-launch lifecycle management, combining payer-focused primary research, evidence synthesis, economic modelling and negotiation training to support pricing, HTA submissions, contracting and uptake across global markets. Part of a larger group that provides data-insight and regulatory/medical communications support.
Industries
Nr. of Employees
small (1-50)
Valid Insight
Macclesfield, Cheshire East, United Kingdom, Europe
Products
Pricing and Market Access Simulator (PMAS)
A simulation tool to explore payer willingness-to-pay dynamics and inform access and pricing strategies.
In-house payer and clinical opinion leader database
A curated database of payers and clinicians to rapidly identify appropriate stakeholders for research and advisory activities.
Pricing and Market Access Simulator (PMAS)
A simulation tool to explore payer willingness-to-pay dynamics and inform access and pricing strategies.
In-house payer and clinical opinion leader database
A curated database of payers and clinicians to rapidly identify appropriate stakeholders for research and advisory activities.
Services
End-to-end strategy development from early development through launch and lifecycle optimisation.
Design and execution of payer, clinician and KOL research to inform pricing, evidence and positioning.
Development of economic models and use of simulation tools to estimate price potential and payer willingness-to-pay.
Preparation of global value dossiers, HTA inputs and dossier inserts to support reimbursement applications.
Training programs, mock negotiations in realistic payer settings and negotiation pathway development to prepare affiliates.
Tender playbooks, risk assessment, summit facilitation and contracting frameworks to support procurement processes.
End-to-end strategy development from early development through launch and lifecycle optimisation.
Design and execution of payer, clinician and KOL research to inform pricing, evidence and positioning.
Development of economic models and use of simulation tools to estimate price potential and payer willingness-to-pay.
Preparation of global value dossiers, HTA inputs and dossier inserts to support reimbursement applications.
Training programs, mock negotiations in realistic payer settings and negotiation pathway development to prepare affiliates.
Tender playbooks, risk assessment, summit facilitation and contracting frameworks to support procurement processes.
Expertise Areas
- Market access strategy
- Payer research and stakeholder engagement
- Pricing and reimbursement
- HTA submissions and dossier development
Key Technologies
- Stakeholder/payer database
- Pricing and market-access simulation models
- Economic and cost-effectiveness modelling
- Systematic literature review and evidence synthesis methods
News & Updates
Appointment to leadership team announced.
New associate director appointment announced.
Director presented on how cognitive biases shape payer decisions.
Whitepaper on how ESG considerations affect market access and procurement.
Webinar recording discussing patient-reported outcomes and HTA engagement.
Publication discussing sustainability in healthcare procurement and ESG integration.
Appointment to leadership team announced.
New associate director appointment announced.
Director presented on how cognitive biases shape payer decisions.
Whitepaper on how ESG considerations affect market access and procurement.
Webinar recording discussing patient-reported outcomes and HTA engagement.
Publication discussing sustainability in healthcare procurement and ESG integration.